Influence of biologic and conventional disease-modifying antirheumatic drugs on COVID-19 incidence among rheumatic patients during the first and second wave of the pandemic in Iran
Sahebari et al., Reumatologia/Rheumatology, doi:10.5114/reum.2022.119039
https://c19hcq.org/sahebari.html